The first United Therapeutics trade was made in Q3 2014.
Since then Steven Cohen bought shares ten more times and sold shares on sixteen occasions. The investor completely sold their stake between Q3 2023 and Q4 2023.
Avg closing price
Price range
Sold -1.04 Thousand shares
Q4 2023
Avg closing price
$230.49
Price range
$214.88
-
$256.94
Sold 91.3% shares (-10.9 Thousand shares)
Q3 2023
Avg closing price
$230.33
Price range
$211.82
-
$248.24
New holding (+11.9 Thousand shares)
Q2 2023
Avg closing price
$221.50
Price range
$205.19
-
$232.99
Sold -19.8 Thousand shares
Q3 2022
Avg closing price
$223.56
Price range
$203.30
-
$244.17
Sold 89.9% shares (-177 Thousand shares)
Q2 2022
Avg closing price
$203.30
Price range
$174.81
-
$241.14
Sold 4.9% shares (-10.1 Thousand shares)
Q1 2022
Avg closing price
$190.51
Price range
$166.16
-
$213.96
Increased shares by 0.1% (+300 shares)
Q4 2021
Avg closing price
$196.31
Price range
$184.32
-
$216.08
Sold 62.5% shares (-346 Thousand shares)
Q3 2021
Avg closing price
$196.97
Price range
$179.86
-
$214.88
New holding (+552 Thousand shares)
Q2 2021
Avg closing price
$190.45
Price range
$170.47
-
$211.93
Sold -343 Thousand shares
Q1 2021
Avg closing price
$166.73
Price range
$153.94
-
$174.85
Sold 22.1% shares (-97.3 Thousand shares)
Q4 2020
Avg closing price
$131.23
Price range
$101.87
-
$151.79
Increased shares by 63.6% (+171 Thousand shares)
Q3 2020
Avg closing price
$109.72
Price range
$99.90
-
$121.13
Sold 53.5% shares (-310 Thousand shares)
Q2 2020
Avg closing price
$112.52
Price range
$92.74
-
$125.82
New holding (+579 Thousand shares)
Q1 2020
Avg closing price
$95.05
Price range
$79.39
-
$115.35
Sold -640 Thousand shares
Q4 2019
Avg closing price
$87.99
Price range
$78.31
-
$95.34
Increased shares by 39.4% (+181 Thousand shares)
Q3 2019